Telix and NUCLIBER Sign Distribution Agreement for Prostate Cancer Imaging in Spain
MELBOURNE, Australia and MADRID, Spain, Dec. 07, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today…
Pharmaceuticals, Biotechnology and Life Sciences
MELBOURNE, Australia and MADRID, Spain, Dec. 07, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today…
COPENHAGEN, Denmark, Dec. 07, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced that the Company will host…
ImprimisRx to assume full responsibility for U.S. sales and marketing activities for DEXYCU® and absorb the majority of EyePoint’s DEXYCU…
MENLO PARK, Calif. and BOSTON, Dec. 07, 2021 (GLOBE NEWSWIRE) — Adicet Bio, Inc. (“Adicet”) (Nasdaq: ACET), a biotechnology company…
SCOTTSDALE, Ariz., Dec. 07, 2021 (GLOBE NEWSWIRE) — Journey Medical Corporation (“Journey Medical”) (NADSAQ: DERM), a commercial-stage pharmaceutical company that…
Proceeds to support the ongoing commercialization of JATENZO® (testosterone undecanoate) NORTHBROOK, Ill., Dec. 07, 2021 (GLOBE NEWSWIRE) — Clarus Therapeutics…
— Recorded Second Quarter Revenue of $26.1 Million — — Initiated Strategic Expansion into Viral Vector Development and Manufacturing Services…
VANCOUVER, British Columbia, Dec. 07, 2021 (GLOBE NEWSWIRE) — Segra International Corp. (“Segra”), an agriculture technology company is pleased to…
Company announcement no. 29 – 21 7 December 2021 Reporting of transactions made by persons discharging managerial responsibilities and persons closely…
A Phase 2 trial of intra-articular RTX for knee OA pain has enrolled its first two patients.The injections were well…